Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

North American Construction stock target cut on first quarter results

EditorNatashya Angelica
Published 02/05/2024, 16:20
LUNA
-
TELL
-
NOA
-
SGBX
-
TLS
-
PUREHEALTH
-

On Thursday, BMO Capital adjusted its outlook on North American Construction Group Ltd. (NYSE:NOA:CN) (NYSE: NOA), reducing the stock price target to Cdn$37.00 from the previous Cdn$39.00. Despite the price target adjustment, the firm maintained its Outperform rating on the stock.

The revision followed the company's first-quarter results for 2024, which met analyst expectations. The performance exhibited weaker results in the Canadian market, which were balanced by robust operations in Australia.

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) guidance for the year 2024 remained unchanged, with projections in the range of $430 to $470 million. North American Construction anticipates a nearly 45%/55% split in earnings between the first and second halves of the year.

Post the quarterly report, BMO Capital revised its stock price target, basing the new target on approximately 3.5 times the expected EV/EBITDA for the year 2025. The firm also noted that it is positioned at the lower end of the company's 2024 EBITDA guidance. The analyst expressed confidence that improvements in the company's performance are likely to be seen in the Canadian market going forward.

North American Construction Group Ltd. has not commented on the revised stock price target. The company's stock performance and investor sentiment will continue to be influenced by its operational results and the execution of its strategic plans in both the Canadian and Australian markets.

InvestingPro Insights

As North American Construction Group Ltd. (NYSE: NOA) navigates through market fluctuations and operational challenges, real-time data from InvestingPro provides a comprehensive picture of the company's financial health.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

With a market capitalization of $548.03 million and a P/E ratio that has adjusted to 12.64 in the last twelve months as of Q1 2024, the company demonstrates a valuation that could attract investors looking for stability. Notably, the company's revenue growth of 20.89% in the same period underscores its capacity to expand its financial base amidst challenging market conditions.

InvestingPro Tips reveal that analysts have a positive outlook on the company's profitability, with three analysts revising their earnings upwards for the upcoming period. This optimism is further supported by the company's track record of maintaining dividend payments for 11 consecutive years, offering a dividend yield of 1.4% as of the latest data. Moreover, the stock generally trades with low price volatility, which may appeal to investors seeking lower-risk equity investments.

For investors seeking more in-depth analysis and additional InvestingPro Tips, a visit to the InvestingPro platform could provide valuable insights. There are more tips available that might help in making a more informed investment decision. To enhance your experience, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.